Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232238PMC
http://dx.doi.org/10.1161/STROKEAHA.122.039534DOI Listing

Publication Analysis

Top Keywords

covid-19-associated cerebral
4
cerebral developmental
4
developmental venous
4
venous anomaly
4
anomaly thrombosis
4
thrombosis hemorrhagic
4
hemorrhagic transformation
4
covid-19-associated
1
developmental
1
venous
1

Similar Publications

Background: Multiple sclerosis (MS) is a complex neurodegenerative disease characterized by immune dysregulation, affecting over 2.5 million people worldwide. Interestingly, COVID-19 infection can cause neurodegeneration through demyelination similar to that of MS, and COVID-19 infection can lead to long-term neurological sequelae, post-COVID-19 neurological syndrome.

View Article and Find Full Text PDF

Limited literature exists regarding specific pharmacological treatments for COVID-19-associated brain fog (BF) syndrome. One previous study using bupropion lacked objectivity. In this multiple baseline case series study, methylphenidate was used in treating post-COVID BF syndrome.

View Article and Find Full Text PDF

The term "brain fog" has emerged from the observations of neuropsychiatric conditions present in post-COVID-19 infections. This is characterized by concentration and memory problems, selective attention disorders and difficulties in executive functions, yet it is unclear how long these deficits may persist and which cognitive functions are most vulnerable. Therefore, there is a need to properly evaluate these cognitive complaints using an assessment tool that specifies their intensity and nature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!